文献速递细菌感染、耐药与抗菌药物

抗微生物耐药肠杆菌属临床分离株可在人巨噬细胞内不复制而持续存在且无明显细胞毒性

Clinical Isolates of Antimicrobial-Resistant Enterobacter Species Can Persist in Human Macrophages Without Replication and Overt Cellular Cytotoxicity.
PubMed 文献 · J Infect Dis · 2025-01-01

研究观察了11株肠杆菌属临床分离株(含黏菌素耐药株)在人原代巨噬细胞内的吞噬、转运与存活。分离株在修饰的晚期吞噬溶酶体腔内长期存活达44小时且不复制,诱导的巨噬细胞毒性低,与促炎标志物未裂解相关。作者认为这或与无法清除肠杆菌感染患者的临床结局相关,可能导致细胞内长期存活和感染复发。

要点

  • 11株肠杆菌属临床分离株在人巨噬细胞内不复制,可存活达44小时。
  • 存活与黏菌素耐药、脂多糖修饰或蜡螟感染模型毒力不相关。
  • 胞内菌诱导巨噬细胞毒性低,与促炎标志物未裂解相关。

核心结论

  • 肠杆菌属临床分离株可在人巨噬细胞内不复制而持续存在,对细胞完整性和炎症影响极小。
  • 作者认为这些观察可能对无法轻易清除肠杆菌感染患者的临床结局有影响,可能导致细胞内长期存活和感染复发。

研究设计与样本

  • 研究纳入11株肠杆菌属临床分离株,代表阴沟肠杆菌、布甘肠杆菌、kobei肠杆菌、湘坊肠杆菌、罗根坎普肠杆菌、霍夫曼肠杆菌和路德维希肠杆菌,在人原代巨噬细胞中研究其吞噬作用。

主要发现

  • 肠杆菌分离株在人巨噬细胞内不复制,在修饰的晚期吞噬溶酶体腔内长期存活达44小时。
  • 存活与黏菌素耐药、脂多糖修饰或蜡螟感染模型中的细菌致病性不相关。
  • 胞内细菌诱导低水平巨噬细胞毒性,与感染巨噬细胞中促炎标志物未裂解相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Enterobacter species are opportunistic, multidrug resistant gram-negative bacteria associated with morbidity and mortality worldwide. Because very little is known about the infection biology of Enterobacter spp, we investigated the intracellular trafficking of a subset of Enterobacter clinical isolates, including colistin-resistant strains, within human macrophages and determined the macrophage response to the intracellular infection. METHODS: Phagocytosis of 11 clinical isolates representing Enterobacter cloacae, Enterobacter bugandensis, Enterobacter kobei, Enterobacter xiangfangensis, Enterobacter roggenkampii, Enterobacter hoffmannii, and Enterobacter ludwigii was investigated in primary human macrophages. Intracellular bacterial trafficking was followed by confocal fluorescence microscopy, intracellular bacterial replication was assessed by bacterial enumeration, and a fluorescence dilution approach was used to follow bacterial cell division over time. Macrophage cell cytotoxicity was investigated by quantifying the release of lactate dehydrogenase during infection and by determining cleavage of the proinflammatory markers caspase-1, gasdermin D, and prointerleukin-1β. RESULTS: Enterobacter isolates did not replicate in human macrophages, exhibiting long-term survival (up to 44 hours) within a modified late phagolysosome compartment. Survival did not correlate with colistin resistance, lipopolysaccharide modifications, or bacterial pathogenicity in the Galleria mellonella infection model. Intracellular bacteria induced low levels of macrophage cytotoxicity that correlated with absence of cleavage of proinflammatory markers in infected macrophages. CONCLUSIONS: Enterobacter spp clinical isolates can persist without replication inside human macrophages with minimal effects on cell integrity and inflammation. These observations could have implications for clinical outcome of patients that cannot readily clear Enterobacter infections, which can potentially lead to prolonged intracellular survival and infection relapse.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Parau G, Parks HJ, Anderson AJG, et al. Clinical Isolates of Antimicrobial-Resistant Enterobacter Species Can Persist in Human Macrophages Without Replication and Overt Cellular Cytotoxicity. J Infect Dis. 2025. PMID: 40037395. doi:10.1093/infdis/jiaf099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。